Bio-Techne Corp
$ 58.49
-0.29%
15 Apr - close price
- Market Cap 9,177,550,000 USD
- Current Price $ 58.49
- High / Low $ 59.78 / 58.09
- Stock P/E 110.68
- Book Value 12.90
- EPS 0.53
- Next Earning Report 2026-05-06
- Dividend Per Share $0.32
- Dividend Yield 0.56 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.04 %
- 52 Week High 72.06
- 52 Week Low 45.74
About
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Analyst Target Price
$73.64
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-04 | 2025-11-05 | 2025-08-06 | 2025-05-07 | 2025-02-05 | 2024-10-30 | 2024-08-07 | 2024-05-01 | 2024-02-01 | 2023-10-31 | 2023-08-08 | 2023-05-03 |
| Reported EPS | 0.46 | 0.42 | 0.53 | 0.56 | 0.42 | 0.42 | 0.49 | 0.48 | 0.4 | 0.41 | 0.55 | 0.53 |
| Estimated EPS | 0.43 | 0.43 | 0.5 | 0.51 | 0.39 | 0.38 | 0.49 | 0.45 | 0.41 | 0.44 | 0.55 | 0.53 |
| Surprise | 0.03 | -0.01 | 0.03 | 0.05 | 0.03 | 0.04 | 0 | 0.03 | -0.01 | -0.03 | 0 | 0 |
| Surprise Percentage | 6.9767% | -2.3256% | 6% | 9.8039% | 7.6923% | 10.5263% | 0% | 6.6667% | -2.439% | -6.8182% | 0% | 0% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.48 |
| Currency | USD |
Previous Dividend Records
| Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Jan 1970 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-02-27 | 2025-11-28 | 2025-08-29 | 2025-05-30 | 2025-02-28 | None | 2024-11-22 | 2024-08-30 | 2024-05-24 | 2024-02-26 |
| Amount | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TECH
2026-04-15 03:38:29
Bio-Techne Corp., a small-cap biotechnology firm, has undergone a stock evaluation revision due to mixed technical indicators and fluctuating performance. The stock is currently priced at $55.54, with its returns showing significant variance compared to the S&P 500, particularly over longer timeframes where it has underperformed. While weekly MACD signals are bearish, monthly signals are mildly bullish, and other indicators suggest a short-term bearish trend and consolidation.
2026-04-14 17:17:00
Bio-Techne Corp. (TECH) shares rose 1.96% to $58.66 on Tuesday, outperforming the broader stock market. The S&P 500 Index increased by 1.18% and the Dow Jones Industrial Average gained 0.66% on the same trading day. This marks the second consecutive day of gains for the company's stock.
2026-04-14 11:08:31
Bio-Techne Corporation announced it will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m. CDT to discuss its third-quarter fiscal 2026 financial results. Interested parties can access the live discussion via dial-in or webcast, with a recorded rebroadcast available afterward. The company, a global life sciences firm, generated over $1.2 billion in net sales in fiscal 2025.
2026-04-14 08:45:37
Bio-Techne Corp (NASDAQ:TECH) has received a "Moderate Buy" consensus recommendation from fourteen brokerages, with an average one-year price target of $72.7692. The company recently reported strong quarterly earnings, beating analyst estimates, and has seen notable institutional investment activity. Bio-Techne also declared a quarterly dividend.
2026-04-14 00:38:30
The article presents financial information for Bio-Techne Corporation, specifically focusing on its operating cash flow per share, as traded on the Dusseldorf Stock Exchange under the ticker TE1. The data is provided by ICE Data Services and FactSet, with SEC filings from Quartr.
2026-04-13 17:17:00
Bio-Techne Corp. (TECH) saw its stock rally by 3.58% to $57.53 on Monday, outperforming the broader stock market, which also experienced a positive trading session. The S&P 500 Index and the Dow Jones Industrial Average both advanced. Despite the gain, Bio-Techne Corp. closed 20.27% below its 52-week high reached on January 22nd.
